Effect of cell passage and density on protein kinase G expression and activation in vascular smooth muscle cells

Guiting Lin1, Sylvia Chow, Jackie Lin

  • 1Knuppe Molecular Urology Laboratory, Department of Urology, School of Medicine, University of California, San Francisco, California 94143-1695, USA.

Insights

Aortic smooth muscle cells (AoSMCs) show stable cyclic GMP-dependent protein kinase 1 (PKG-I) expression across passages and densities. However, PKG-I activation decreases with increasing cell passage.

Area of Science:

  • Vascular Biology
  • Cellular Physiology
  • Molecular Cardiology

Background:

  • Previous studies suggested cyclic GMP-dependent protein kinase 1 (PKG-I) expression decreases in propagated rat aortic smooth muscle cells (AoSMCs).
  • However, PKG-I deficient mice AoSMCs exhibit normal morphology and growth, questioning the impact of PKG-I loss.

Purpose of the Study:

  • To investigate the effect of cell passage and density on PKG-I expression and activation in human and rat AoSMCs.
  • To determine if cell passage influences PKG-I mediated signaling.

Main Methods:

  • Western blotting and immunofluorescence microscopy were used to assess PKG-I expression in human and rat AoSMCs across passages (p9-p15 and p1-p15, respectively).
  • Rat AoSMCs were cultured at varying densities to evaluate PKG-I expression.
  • PKG-I activation was assessed by measuring phosphorylated vasodilator-stimulated phosphoprotein (P-VASP) levels in response to cGMP stimulation in cells from different passages (p4 vs. p11).

Main Results:

  • Little difference in PKG-I expression was observed among different passages (p9-p15 for human, p1-p15 for rat) and cell densities.
  • Rat AoSMCs from passage 4 (p4) exhibited higher PKG-I activation compared to those from passage 11 (p11), as indicated by P-VASP levels.

Conclusions:

  • Cell passage and density do not significantly alter PKG-I expression levels in AoSMCs.
  • Higher cell passage number is associated with reduced PKG-I activation, suggesting a potential decline in signaling capacity over time.

Related Concept Videos

Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
What are Second Messengers?01:12

What are Second Messengers?

Because many receptor binding ligands are hydrophilic, they do not cross the cell membrane and thus their message must be relayed to a second messenger on the inside. There are several second messenger pathways, each with their own way of relaying information. G-protein coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol path is active when the receptor induces phospholipase C to hydrolyze the phospholipid,...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...